本页面由Tiger Trade Technology Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc.

0.7709
-0.0741-8.77%
盘后0.78000.0091+1.18%19:59 EDT
成交量:48.42万
成交额:38.14万
市值:981.12万
市盈率:-0.14
高:0.8568
开:0.8568
低:0.7600
收:0.8450
52周最高:23.20
52周最低:0.5900
股本:1,272.70万
流通股本:1,255.13万
量比:0.54
换手率:3.86%
股息:- -
股息率:- -
每股收益(TTM):-5.4800
每股收益(LYR):-18.0520
净资产收益率:-419.97%
总资产收益率:-80.35%
市净率:1.13
市盈率(LYR):-0.04

数据加载中...

2021/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/04

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K/A [Amend] - Current report
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/18

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/12/14

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/12/09

重要事件披露

8-K - Current report
2020/11/19

企业合并公告

425 - Prospectuses and communications, business combinations
2020/11/19

重要事件披露

8-K - Current report